Abstract:Deep learning methods, trained on the increasing set of available protein 3D structures and sequences, have substantially impacted the protein modeling and design field. These advancements have facilitated the creation of novel proteins, or the optimization of existing ones designed for specific functions, such as binding a target protein. Despite the demonstrated potential of such approaches in designing general protein binders, their application in designing immunotherapeutics remains relatively underexplored. A relevant application is the design of T cell receptors (TCRs). Given the crucial role of T cells in mediating immune responses, redirecting these cells to tumor or infected target cells through the engineering of TCRs has shown promising results in treating diseases, especially cancer. However, the computational design of TCR interactions presents challenges for current physics-based methods, particularly due to the unique natural characteristics of these interfaces, such as low affinity and cross-reactivity. For this reason, in this study, we explored the potential of two structure-based deep learning protein design methods, ProteinMPNN and ESM-IF1, in designing fixed-backbone TCRs for binding target antigenic peptides presented by the MHC through different design scenarios. To evaluate TCR designs, we employed a comprehensive set of sequence- and structure-based metrics, highlighting the benefits of these methods in comparison to classical physics-based design methods and identifying deficiencies for improvement. Redirecting T cells to recognize and combat infected or altered cells through the engineering of T cell receptors (TCR) has shown promising results, particularly in immunotherapy against cancer. Leveraging breakthroughs in deep learning within the biosciences, this study explores whether deep learning architectures for general protein design, such as ProteinMPNN and ESM-IF1, can design TCRs to bind target antigenic peptides presented by the MHC (pMHC) based on fixed-backbone structures of the complexes. We utilized a comprehensive set of sequence-based and structure-based metrics, derived from deep learning or classical physics-based principles, to evaluate the generated TCR designs. Our findings highlight the benefits of these methods compared to traditional physics-based design approaches and pinpoint deficiencies for improvement. The results contribute to advancements in the field of TCR design, serving as a guiding framework for the structure-based design of TCRs using deep learning, thereby providing the basis for computational engineering of specific TCRs for T cell-based immunotherapy.

Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens

Identification and affinity enhancement of T-cell receptor targeting a KRAS G12V cancer neoantigen

A Computational Strategy for the Rapid Identification and Ranking of Patient‐Specific T cell Receptors Bound to Neoantigens

Structural basis for self-discrimination by neoantigen-specific TCRs

Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity

Identifying and engineering TCR specificity against solid tumor neoantigens

Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?

Identification and Structural Characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3

NeoTCR: an immunoinformatic database of experimentally-supported functional neoantigen-specific TCR sequences

NetTCR-2.1: Lessons and guidance on how to develop models for TCR specificity predictions

Identification and structural characterization of a mutant KRAS‐G12V specific TCR restricted by HLA‐A3

Identification of Novel KRASG12D Neoantigen Specific TCRs and a Strategy to Eliminate Off-Target Recognition

TCRfp: a new fingerprint-based approach for TCR repertoire analysis

RACER-m leverages structural features for sparse T cell specificity prediction

TCRfinder: Improved TCR virtual screening for novel antigenic peptides with tailored language models

Exploring the potential of structure-based deep learning approaches for T cell receptor design

Abstract A168: T cell receptor-based bispecific molecules targeting KRAS neoantigen cancer driver mutations

Structural and Dynamic-Based Characterization of the Recognition Patterns of E7 and TRP-2 Epitopes by MHC Class I Receptors through Computational Approaches

Strengths and limitations of web servers for the modeling of TCRpMHC complexes

High-affinity oligoclonal TCRs define effective adoptive T cell therapy targeting mutant KRAS-G12D